X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (223) 223
Publication (29) 29
Book / eBook (20) 20
Book Review (6) 6
Book Chapter (3) 3
Conference Proceeding (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (161) 161
animals (140) 140
mice (92) 92
oncology (81) 81
index medicus (67) 67
cell biology (64) 64
biochemistry & molecular biology (61) 61
phosphorylation (60) 60
pyrimidines - pharmacology (51) 51
imatinib mesylate (50) 50
protein-tyrosine kinases - antagonists & inhibitors (50) 50
signal transduction (44) 44
benzamides (43) 43
cancer (43) 43
oncogenes (42) 42
chronic myelogenous leukemia (40) 40
piperazines - pharmacology (38) 38
cell line (37) 37
bcr-abl (36) 36
enzyme inhibitors - pharmacology (36) 36
oncogene proteins v-abl - antagonists & inhibitors (35) 35
apoptosis (32) 32
antineoplastic agents - pharmacology (31) 31
hematology (31) 31
protein-tyrosine kinases - metabolism (31) 31
c-abl (30) 30
chronic myeloid-leukemia (30) 30
hemic and lymphatic diseases (30) 30
research (30) 30
proto-oncogene proteins c-abl - metabolism (29) 29
proto-oncogene proteins c-abl - antagonists & inhibitors (28) 28
tyrosine kinase (28) 28
physiological aspects (25) 25
genetics & heredity (24) 24
protein kinase inhibitors - pharmacology (24) 24
transfection (24) 24
genetic aspects (23) 23
antineoplastic agents - therapeutic use (22) 22
cell transformation, neoplastic (22) 22
neoplasms (22) 22
tumors (22) 22
mutation (21) 21
oncogene proteins v-abl - metabolism (21) 21
philadelphia-chromosome (21) 21
protein (21) 21
proteins (21) 21
cell line, tumor (20) 20
enzyme activation (20) 20
growth (20) 20
proto-oncogene proteins - metabolism (20) 20
cells (19) 19
gene expression (19) 19
kinases (19) 19
molecular sequence data (19) 19
oncogene (19) 19
tumor cells, cultured (19) 19
apoptosis - drug effects (18) 18
female (18) 18
imatinib (18) 18
activation (17) 17
amino acid sequence (17) 17
gene (17) 17
oncogene proteins v-abl - genetics (17) 17
phosphorylation - drug effects (17) 17
proto-oncogene proteins c-abl - genetics (17) 17
pyrimidines - therapeutic use (17) 17
signal transduction - drug effects (17) 17
signal transduction - physiology (17) 17
transformation (17) 17
tyrosine (17) 17
article (16) 16
cell cycle (16) 16
cells, cultured (16) 16
expression (16) 16
leukemia (16) 16
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (16) 16
medicine (16) 16
multidisciplinary sciences (16) 16
protein binding (16) 16
in-vivo (15) 15
rats (15) 15
cell division - drug effects (14) 14
dna-binding proteins - metabolism (14) 14
enzyme inhibitors - therapeutic use (14) 14
gene expression regulation (14) 14
gene expression regulation, neoplastic (14) 14
genes, abl (14) 14
inhibition (14) 14
male (14) 14
piperazines - therapeutic use (14) 14
research article (14) 14
3t3 cells (13) 13
cell line, transformed (13) 13
medicine, research & experimental (13) 13
tyrosine kinase inhibitor (13) 13
acute lymphoblastic-leukemia (12) 12
c-myc (12) 12
k562 cells (12) 12
p53 (12) 12
pharmacology & pharmacy (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2005, Volume 102, Issue 31, pp. 11011 - 11016
Journal Article
Blood, ISSN 0006-4971, 02/2016, Volume 127, Issue 17, pp. 2131 - 2143
Leukemias expressing constitutively activated mutants of ABL1 tyrosine kinase (BCR-ABL1, TEL-ABL1, NUP214-ABL1) usually contain at least 1 normal ABL1 allele.... 
CHRONIC MYELOGENOUS LEUKEMIA | GENOMIC INSTABILITY | APOPTOTIC RESPONSE | CELL-DEATH RESPONSE | C-ABL | TYROSINE KINASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | BCR-ABL | DNA-DAMAGE | HEMATOLOGY | CHRONIC MYELOID-LEUKEMIA | Oxidative Stress | Apoptosis - drug effects | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myeloid, Chronic-Phase - pathology | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Proto-Oncogene Proteins c-abl - physiology | Imatinib Mesylate - therapeutic use | Imidazoles - therapeutic use | Neoplasm Proteins - genetics | Genes, Tumor Suppressor | Proto-Oncogene Proteins c-abl - genetics | Blast Crisis - pathology | Imatinib Mesylate - pharmacology | Leukemia, Experimental - drug therapy | Oncogene Proteins v-abl - genetics | Leukemia, Myeloid, Chronic-Phase - drug therapy | Gene Expression Regulation, Leukemic - drug effects | Imidazoles - pharmacology | Leukemia, Myeloid, Chronic-Phase - enzymology | Cell Division - drug effects | Tumor Suppressor Proteins - physiology | Cell Line, Tumor | Mice, Inbred NOD | Blast Crisis - genetics | Mice | Leukemia, Myeloid, Chronic-Phase - genetics | Oncogene Proteins v-abl - physiology | Genomic Instability | Blast Crisis - drug therapy | Tumor Suppressor Proteins - antagonists & inhibitors | Neoplasm Proteins - physiology | Oncogene Proteins v-abl - antagonists & inhibitors | Leukemia, Experimental - enzymology | Pyridazines - pharmacology | Blast Crisis - enzymology | Oncogene Proteins, Fusion - physiology | Tumor Suppressor Proteins - genetics | Antineoplastic Agents - pharmacology | Cytostatic Agents - pharmacology | Pyridazines - therapeutic use | Leukemia, Experimental - genetics | Leukemia, Experimental - pathology | Mice, SCID | Animals | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Genes, abl | Oncogene Proteins, Fusion - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Neoplastic Stem Cells - enzymology | Myeloid Neoplasia
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 48, pp. 79842 - 79853
Journal Article
European Journal of Haematology, ISSN 0902-4441, 05/2011, Volume 86, Issue 5, pp. 361 - 371
Journal Article
Journal of Immunological Methods, ISSN 0022-1759, 12/2017, Volume 451, pp. 71 - 77
Antigen receptor gene assembly is accomplished in developing lymphocytes by the V(D)J recombination reaction, which can be separated into two steps: DNA... 
Nonhomologous end joining (NHEJ) | v-Abl transformed pro-B cells | Recombination-activating gene (RAG) endonuclease | CRISPR/Cas9-mediated gene knock-out | V(D)J recombination | STRAND BREAK REPAIR | XRCC4 | BIOCHEMICAL RESEARCH METHODS | IMMUNOLOGY | GENOME | XLF | PAXX | PATHWAY | LIGASE IV | MICE | END RESECTION | DIFFERENTIATION | Apoptosis - drug effects | Homeodomain Proteins - metabolism | Oncogene Proteins v-abl - antagonists & inhibitors | Precursor Cells, B-Lymphoid - metabolism | Precursor Cells, B-Lymphoid - drug effects | DNA Breaks, Double-Stranded | DNA-Binding Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Precursor Cells, B-Lymphoid - pathology | DNA End-Joining Repair | Clustered Regularly Interspaced Short Palindromic Repeats | Recombinational DNA Repair - drug effects | CRISPR-Associated Proteins - genetics | Imatinib Mesylate - pharmacology | Oncogene Proteins v-abl - genetics | Mice, Inbred C57BL | Genotype | DNA-Binding Proteins - genetics | Homeodomain Proteins - genetics | Oncogene Proteins v-abl - metabolism | Phenotype | Animals | CRISPR-Associated Proteins - metabolism | CRISPR-Cas Systems | Gene Editing - methods | Protein Kinase Inhibitors - pharmacology | G1 Phase Cell Cycle Checkpoints - drug effects | Proto-Oncogene Proteins c-bcl-2 - genetics | Cell Line, Transformed | CRISPR | Cas9-mediated gene knock-out
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2017, Volume 12, Issue 11, p. e0187173
Journal Article
Clinical Immunology, ISSN 1521-6616, 2008, Volume 127, Issue 3, pp. 330 - 339
Journal Article
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 12/2008, Volume 15, Issue 29, pp. 3036 - 3051
Chronic myeloid leukemia (CML) is characterized by the presence of the Philadelphia (Ph) chromosome, which results from a reciprocal translocation between the... 
Nilotinib | Dasatinib | Imatinib | INNO-406 | MK-0457 | Chronic myeloid leukemia | Bosutinib | Tyrosine kinase inhibitors | CHRO